A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)

Summary

MK-8294, the study medicine, is a type of targeted therapy designed to treat certain solid tumors. The main goals of this study are to learn about the safety of MK-8294 and if people can tolerate it and find the highest dose level of MK-8294 that people can tolerate.

Timeline

Start

2025-07-23

Primary completion

2029-07-01

Completion

2029-07-01

Drugs

Indications